We evaluated the performance of the Abbott BinaxNOW rapid antigen test for coronavirus
disease 2019 (Binax-CoV2) to detect virus among persons, regardless of symptoms, at a …

Background COVID-19 vaccine coverage in the Latinx community depends on delivery systems
that overcome barriers such as institutional distrust, misinformation, and access to care. …

We evaluated the performance of the Abbott BinaxNOW™ Covid-19 rapid antigen test to
detect virus among persons, regardless of symptoms, at a public plaza site of ongoing …

Background We characterized SARS-CoV-2 infections in a densely-populated, majority
Latinx San Francisco community six-weeks into the city’s shelter-in-place order. Methods We …

Background After a COVID-19 diagnosis, vulnerable populations face considerable logistical
and financial challenges to isolate and quarantine. We developed and evaluated a novel, …

Background There is an urgent need to understand the dynamics and risk factors driving
ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission during …

Among 3302 persons tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
by BinaxNOW TM and reverse transcription polymerase chain reaction (RT-PCR) in a …

… , Francine Rios-Fetchko, Elizabeth Imbert, MD, MPH, Cynthia Nagendra, JD, Eva Pardo, MPH,
Ghilamichael Andemeskel, Susana Rojas, Jon Jacobo, Valerie Tulier-Laiwa, JD, MPA, Monique …

Background Rapid coronavirus disease 2019 (COVID-19) diagnosis and isolation of infectious
persons are critical to stopping forward transmission, and the care cascade framework …

Background Sequencing of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
viral genome from patient samples is an important epidemiological tool for monitoring …